chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Influenza like illness, Injection site erythema, Injection site pain
Clinical narrative: pain at injection site; redness at injection site; fever of 102 degrees; flu like symptoms; fatigue; sleepiness; feels noticeably without energy; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included INFLUENZA SHOT with an associated reaction of chronic fatigue syndrome (Approximately 20 years before from the time of reporting (refer case US2019GSK088484) ).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy. On an unknown date, the outcome of the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient experienced fatigue that causes her to need to take naps and sleep longer at night and she feels noticeably without energy. The patient received flu shot (formulation/brand name unknown) that contained thimerosal. The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up. For tolerance to 2nd dose, refer case US2019083179.      Lab Comments: On an unknown date, body temperature was recorded.
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Somnolence
Clinical narrative: pain at injection site; redness at injection site; fever of 102 degrees; flu like symptoms; fatigue; sleepiness; feels noticeably without energy; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included INFLUENZA SHOT with an associated reaction of chronic fatigue syndrome (Approximately 20 years before from the time of reporting (refer case US2019GSK088484) ).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy. On an unknown date, the outcome of the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient experienced fatigue that causes her to need to take naps and sleep longer at night and she feels noticeably without energy. The patient received flu shot (formulation/brand name unknown) that contained thimerosal. The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up. For tolerance to 2nd dose, refer case US2019083179.      Lab Comments: On an unknown date, body temperature was recorded.
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Chronic fatigue syndrome
Clinical narrative: Chronic fatigue syndrome; This case was reported by a consumer via call center representative and described the occurrence of chronic fatigue syndrome in a elderly female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced chronic fatigue syndrome. On an unknown date, the outcome of the chronic fatigue syndrome was unknown.   It was unknown if the reporter considered the chronic fatigue syndrome to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not provided. At the time of reporting, approximately 20 years before the patient received flu shot(formulation/brand name unknown) that contained thimerosal and the patient experienced chronic fatigue syndrome.  The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up This case is linked to cases US2019083179 and US2019GSK088465, reported for the same patient.      Lab Comments: Lab test performed on an unknown date.
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Asthenia, Fatigue, Influenza like illness, Injection site erythema, Injection site pain
Clinical narrative: Chronic fatigue syndrome; This case was reported by a consumer via call center representative and described the occurrence of chronic fatigue syndrome in a elderly female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced chronic fatigue syndrome. On an unknown date, the outcome of the chronic fatigue syndrome was unknown.   It was unknown if the reporter considered the chronic fatigue syndrome to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not provided. At the time of reporting, approximately 20 years before the patient received flu shot(formulation/brand name unknown) that contained thimerosal and the patient experienced chronic fatigue syndrome.  The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up This case is linked to cases US2019083179 and US2019GSK088465, reported for the same patient.      Lab Comments: Lab test performed on an unknown date.
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Pyrexia, Somnolence, Vaccine positive rechallenge
Clinical narrative: Chronic fatigue syndrome; This case was reported by a consumer via call center representative and described the occurrence of chronic fatigue syndrome in a elderly female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced chronic fatigue syndrome. On an unknown date, the outcome of the chronic fatigue syndrome was unknown.   It was unknown if the reporter considered the chronic fatigue syndrome to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not provided. At the time of reporting, approximately 20 years before the patient received flu shot(formulation/brand name unknown) that contained thimerosal and the patient experienced chronic fatigue syndrome.  The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up This case is linked to cases US2019083179 and US2019GSK088465, reported for the same patient.      Lab Comments: Lab test performed on an unknown date.
Age: 69.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Chronic fatigue syndrome
Clinical narrative: pain at injection site; redness at injection site; fever of 102 degrees; flu like symptoms; fatigue; sleepiness; feels noticeably without energy; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received several months before the second dose (refer case US2019GSK088465)) and INFLUENZA SHOT with an associated reaction of chronic fatigue syndrome (Approximately 20 years before from the time of reporting (refer case US2019GSK088484)).   On 25th April 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, injection site erythema, fever and influenza-like symptoms were recovered/resolved and the outcome of the fatigue and sleepiness were not recovered/not resolved and the outcome of the loss of energy was unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The patient experienced fever of 102 degrees and fatigue causes her to need to take naps and sleep longer at night and she feels noticeably without energy. Patient reported that she experienced all of this events with the first dose but it resolved within a couple days. The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up      Lab Comments: Lab test performed on an unknown date.
Age: 69.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Asthenia, Fatigue, Influenza like illness, Injection site erythema, Injection site pain
Clinical narrative: pain at injection site; redness at injection site; fever of 102 degrees; flu like symptoms; fatigue; sleepiness; feels noticeably without energy; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received several months before the second dose (refer case US2019GSK088465)) and INFLUENZA SHOT with an associated reaction of chronic fatigue syndrome (Approximately 20 years before from the time of reporting (refer case US2019GSK088484)).   On 25th April 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, injection site erythema, fever and influenza-like symptoms were recovered/resolved and the outcome of the fatigue and sleepiness were not recovered/not resolved and the outcome of the loss of energy was unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The patient experienced fever of 102 degrees and fatigue causes her to need to take naps and sleep longer at night and she feels noticeably without energy. Patient reported that she experienced all of this events with the first dose but it resolved within a couple days. The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up      Lab Comments: Lab test performed on an unknown date.
Age: 69.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Pyrexia, Somnolence, Vaccine positive rechallenge
Clinical narrative: pain at injection site; redness at injection site; fever of 102 degrees; flu like symptoms; fatigue; sleepiness; feels noticeably without energy; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received several months before the second dose (refer case US2019GSK088465)) and INFLUENZA SHOT with an associated reaction of chronic fatigue syndrome (Approximately 20 years before from the time of reporting (refer case US2019GSK088484)).   On 25th April 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, injection site erythema, fever and influenza-like symptoms were recovered/resolved and the outcome of the fatigue and sleepiness were not recovered/not resolved and the outcome of the loss of energy was unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, fever, influenza-like symptoms, fatigue, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The patient experienced fever of 102 degrees and fatigue causes her to need to take naps and sleep longer at night and she feels noticeably without energy. Patient reported that she experienced all of this events with the first dose but it resolved within a couple days. The reporter did not consent to follow-up. Caller notes stated that caller declined for prescriber follow up      Lab Comments: Lab test performed on an unknown date.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Influenza, Product supply issue
Clinical narrative: flu; Product supply issue; This case was reported by a pharmacist via call center representative and described the occurrence of flu in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included multiple sclerosis.   On 17th September 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced flu and product supply issue. On an unknown date, the outcome of the flu and product supply issue were unknown.   It was unknown if the reporter considered the flu to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for the 2nd Shingrix dose. The pharmacist reported that she had a patient who had not been able to get the 2nd Shingrix dose due to availability and health issues.  The patient inquired if she would get the 2nd dose or she would need to restart. The pharmacist probed further to see what health issues the patient had, and the patient confirmed that she had multiple sclerosis, but had it prior to receiving the vaccine.  The pharmacist stated that the patient contracted the flu sometime during the winter after receiving the vaccine.  It was unknown whether the two (multiple sclerosis and flu) were related. The pharmacist preferred not to leave the patient's initials.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscle tightness, Paraesthesia oral
Clinical narrative: tightness in lower neck; tingling lips; This case was reported by a pharmacist via call center representative and described the occurrence of tightness of back muscles in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th May 2019, the patient received Shingrix. On 7th May 2019, less than a day after receiving Shingrix, the patient experienced tightness of back muscles and tingling lips. On an unknown date, the outcome of the tightness of back muscles and tingling lips were unknown.   It was unknown if the reporter considered the tightness of back muscles and tingling lips to be related to Shingrix.  Additional details were provided as follows: The patient experienced tightness in her lower neck and tingling lips.
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Urticaria
Clinical narrative: Hives; Rash; This case was reported by a pharmacist via call center representative and described the occurrence of generalized urticaria in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number E927Z, expiry date 27th February 2021) for prophylaxis.   On 29th August 2018, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced generalized urticaria and rash. The patient was treated with prednisone. On an unknown date, the outcome of the generalized urticaria and rash were not recovered/not resolved.   It was unknown if the reporter considered the generalized urticaria and rash to be related to Shingrix.  Additional details were provided as follows: The patient had generalized hives after vaccination of Shingrix and breakouts since the administration. The patient had no problem until administration of 2nd dose of Shingrix. The patient stated that, the hives gone, when the patient taken prednisone, but still had reoccurence of symptoms.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site irritation, Injection site rash, Injection site warmth
Clinical narrative: site of the injection was red; Red rash; site of the injection irritated; Warm to the touch; This case was reported by a pharmacist via call center representative and described the occurrence of injection site irritation in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number HB2B2, expiry date 13th April 2020) for prophylaxis.   On 2nd May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In May 2019, less than a week after receiving Shingrix, the patient experienced injection site irritation, injection site warmth, injection site erythema and injection site rash. On an unknown date, the outcome of the injection site irritation and injection site warmth were recovered/resolved and the outcome of the injection site erythema and injection site rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site irritation, injection site warmth, injection site erythema and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient for the first 36 hours experienced red, warm to the touch, and irritated. The events went away and patient went to the beach and the same area of the injection was exposed to the sun for 12 hours and the red rash reappeared. The initial reaction lasted for a day and a half and then recovered. No further information provided regarding timing of events.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles
Clinical narrative: little blisters at the injection site; swelling at the injection site; redness at the injection site; pain at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th May 2019, the patient received the 1st dose of Shingrix (intramuscular). On 7th May 2019, 1 days after receiving Shingrix, the patient experienced injection site swelling, injection site erythema and injection site pain. On 8th May 2019, the patient experienced injection site blisters. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site pain and injection site blisters were recovering/resolving.   It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site pain and injection site blisters to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left deltoid. Two days after vaccination, the patient expereinced blisters at injection site. The reporter consented to follow up.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site bruising, Injection site erythema, Injection site pain
Clinical narrative: itching at injection site; bruising at injection site; headache; pain at injection site; redness at injection site; chills; not feeling well; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th April 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th April 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site erythema, chills and feeling unwell. On 1st May 2019, the patient experienced headache. On 3rd May 2019, the patient experienced injection site itching and injection site bruising. On 1st May 2019, the outcome of the chills and feeling unwell were recovered/resolved. On 2nd May 2019, the outcome of the headache was recovered/resolved. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site itching and injection site bruising were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, chills, feeling unwell, headache, injection site itching and injection site bruising to be related to Shingrix.  Additional case details were provided as follows: The patient received the dose of Shingrix in the left arm and experienced injection site pain, injection site erythema, chills and feeling unwell, headache, injection site itching and injection site bruising. The patient has been given the consent for follow up. The outcome reported for all AES in the structured field of XML is recovering/recovered with sequel  instead of resolved.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Malaise
Clinical narrative: itching at injection site; bruising at injection site; headache; pain at injection site; redness at injection site; chills; not feeling well; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th April 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th April 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site erythema, chills and feeling unwell. On 1st May 2019, the patient experienced headache. On 3rd May 2019, the patient experienced injection site itching and injection site bruising. On 1st May 2019, the outcome of the chills and feeling unwell were recovered/resolved. On 2nd May 2019, the outcome of the headache was recovered/resolved. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site itching and injection site bruising were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, chills, feeling unwell, headache, injection site itching and injection site bruising to be related to Shingrix.  Additional case details were provided as follows: The patient received the dose of Shingrix in the left arm and experienced injection site pain, injection site erythema, chills and feeling unwell, headache, injection site itching and injection site bruising. The patient has been given the consent for follow up. The outcome reported for all AES in the structured field of XML is recovering/recovered with sequel  instead of resolved.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Cellulitis, Erythema, Pain, Swelling
Clinical narrative: Patient presented to the clinic on 5/16/19 C/O pain, redness and swelling measured about 4 inches x 4.5 inches. Patient's mother reports symptoms began 24 hrs after vaccination. Dr. evaluated patient and prescribed Benadryl 25mg capsule q6h PRN and clindamycin 300mg caps TID x 10 days. Patient will f/u in 1 week on 5/24/18 for cellulitis.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Gynaecomastia
Clinical narrative: Gynecomastia unilateral within a week after Gardasil vaccination. Resolved over two months
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient came in today to report he had an outbreak of Shingles. He received vaccination on 05/06/2019 and the symptoms began shortly after. He went to see a doctor who confirmed he did have Shingles and prescribed the patient an antiviral.
Age: 60.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, warmth to site
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Angiogram normal, Antiacetylcholine receptor antibody, Blood glucose normal, Diplopia, Facial paralysis
Clinical narrative: 5/4/19 Developed visual disturbance "my eyes don't seem to be working together when I turn my head", while visiting out of state.  Became progressively worse over the next several days ending with double vision in the distance when looking straight ahead and upon turning head to right or left; near and far away.   Upon return to home, on 5/9/19, saw ophthalmologist who diagnosed VII nerve palsy of unknown origin.  Recommended lab work and possible MRI/MRA to Primary Care Physician.  On 5/10/19, diplopia was present near and far regardless of head position.  Seen in PCP office and referred to local emergency room.  As of 5/17/19, vision looking forward is clear; doubles as the day progresses; vision to right and left are double, but overall seem to be improving.  Referred to neuro-ophthalmologist and neurologist, who does not have an available appointment until October.  Has follow up with Ophthalmologist on 5/24/19.  Followed up with PCP on 5/15/19.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Full blood count normal, Glycosylated haemoglobin, Metabolic function test normal, Nuclear magnetic resonance imaging brain normal, Prothrombin level normal
Clinical narrative: 5/4/19 Developed visual disturbance "my eyes don't seem to be working together when I turn my head", while visiting out of state.  Became progressively worse over the next several days ending with double vision in the distance when looking straight ahead and upon turning head to right or left; near and far away.   Upon return to home, on 5/9/19, saw ophthalmologist who diagnosed VII nerve palsy of unknown origin.  Recommended lab work and possible MRI/MRA to Primary Care Physician.  On 5/10/19, diplopia was present near and far regardless of head position.  Seen in PCP office and referred to local emergency room.  As of 5/17/19, vision looking forward is clear; doubles as the day progresses; vision to right and left are double, but overall seem to be improving.  Referred to neuro-ophthalmologist and neurologist, who does not have an available appointment until October.  Has follow up with Ophthalmologist on 5/24/19.  Followed up with PCP on 5/15/19.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Scan with contrast normal, Visual impairment
Clinical narrative: 5/4/19 Developed visual disturbance "my eyes don't seem to be working together when I turn my head", while visiting out of state.  Became progressively worse over the next several days ending with double vision in the distance when looking straight ahead and upon turning head to right or left; near and far away.   Upon return to home, on 5/9/19, saw ophthalmologist who diagnosed VII nerve palsy of unknown origin.  Recommended lab work and possible MRI/MRA to Primary Care Physician.  On 5/10/19, diplopia was present near and far regardless of head position.  Seen in PCP office and referred to local emergency room.  As of 5/17/19, vision looking forward is clear; doubles as the day progresses; vision to right and left are double, but overall seem to be improving.  Referred to neuro-ophthalmologist and neurologist, who does not have an available appointment until October.  Has follow up with Ophthalmologist on 5/24/19.  Followed up with PCP on 5/15/19.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Sore arm and erythema around the site of injection. started the date of the injection
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Nodule, Peripheral swelling
Clinical narrative: RED, SWELLING, KNOT ON BOTH ARMS
Age: 8.0
Sex: F
Vaccine: HEPA
Symptoms: Loss of personal independence in daily activities, Pyrexia, Vaccination complication, Vomiting
Clinical narrative: Pts mother called clinic, stating that the child had a reaction to the vaccine, has been throwing up and with a fever of  101-102  since Monday 05/13, was called from school that  the child needed to be picked up.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Inflammation, Pyrexia, Skin warm
Clinical narrative: red inflamed area,  hot to the touch, also running fever
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Erythema, Headache, Malaise, Nausea
Clinical narrative: Woke up nauseated and occiptal headache at 6:00am, usual time but nausea has increased as the day has progressed, time now 1:18pm and I decided to look up the side effects, left arm swollen, mildly red, chills but no fever started about an hour ago.  I usually have lots of energy as I am a Realtor, but today, I will stay around my home.  General malaise.    Wanted to share as I hope it may help others.  I am a retired Nurse.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Peripheral swelling
Clinical narrative: Woke up nauseated and occiptal headache at 6:00am, usual time but nausea has increased as the day has progressed, time now 1:18pm and I decided to look up the side effects, left arm swollen, mildly red, chills but no fever started about an hour ago.  I usually have lots of energy as I am a Realtor, but today, I will stay around my home.  General malaise.    Wanted to share as I hope it may help others.  I am a retired Nurse.
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Irritability, Local reaction
Clinical narrative: Almost immediately developed irritability/fussiness, which lasted for 6 days. On day 2 following injection her right thigh became swollen, red, and firm. Local reaction peaked on day 3, then subsided gradually-gone by day 6. For entire week following immunization, sleep was very disturbed-child waking frequently (every 30 min to 1 hour)- fussy/irritable. Symptoms resolved by day 6
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Sleep disorder
Clinical narrative: Almost immediately developed irritability/fussiness, which lasted for 6 days. On day 2 following injection her right thigh became swollen, red, and firm. Local reaction peaked on day 3, then subsided gradually-gone by day 6. For entire week following immunization, sleep was very disturbed-child waking frequently (every 30 min to 1 hour)- fussy/irritable. Symptoms resolved by day 6
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Increased tendency to bruise, Rash, Rash erythematous, Skin warm
Clinical narrative: About 5 inches lower on the same arm the patient has a palm size red rash that is semi painful at touch and warm to touch.  No treatment currently.
Age: 1.08
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Rash generalised, Rash macular
Clinical narrative: Full body, fine macular rash with confluence.
Age: 13.0
Sex: M
Vaccine: TD
Symptoms: Affect lability, Crying, Disturbance in attention, Educational problem, New daily persistent headache
Clinical narrative: Patient with daily/consistent headaches and complaints of "cannot focus", decline in school performance (math) and emotional liability (crying every evening) beginning with in 24 hours of vaccination. Never had theses symptoms prior. No other medical explanation of symptoms.
Sex: M
Vaccine: VARCEL
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blister, Irritability, Leukopenia
Clinical narrative: 4wo term infant with VZV PCR confirmed rash that began on DOL24. Mother varicella IgG neg so given VAR postnatally on infant's DOL2 while in room with infant. Mother developed 1 itchy papule at vaccine site (RUE). No known rash or varicella contacts. Fussy and tactile fever at home. Admitted with fussiness and known varicella, started on acyclovir - currently on day 3.
Sex: M
Vaccine: VARCEL
Symptoms: Platelet count decreased, Polymerase chain reaction positive, Pyrexia, Rash, Thrombocytopenia
Clinical narrative: 4wo term infant with VZV PCR confirmed rash that began on DOL24. Mother varicella IgG neg so given VAR postnatally on infant's DOL2 while in room with infant. Mother developed 1 itchy papule at vaccine site (RUE). No known rash or varicella contacts. Fussy and tactile fever at home. Admitted with fussiness and known varicella, started on acyclovir - currently on day 3.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine, Varicella virus test positive, White blood cell count decreased
Clinical narrative: 4wo term infant with VZV PCR confirmed rash that began on DOL24. Mother varicella IgG neg so given VAR postnatally on infant's DOL2 while in room with infant. Mother developed 1 itchy papule at vaccine site (RUE). No known rash or varicella contacts. Fussy and tactile fever at home. Admitted with fussiness and known varicella, started on acyclovir - currently on day 3.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Myalgia, severe headache, shivering, fever.
Age: 17.0
Sex: M
Vaccine: HPV9
Symptoms: Cold sweat, Dizziness, Headache, Injection site pain, Pallor
Clinical narrative: Patient experienced pain in the arm where the shot was given, dizziness, headache and fainting 2 minutes after injection. Patient stated he felt fine right after the vaccine and sat on the table for a minute. But once he got to the front desk he felt faint and sat on the ground. The medical staff took the patient to a open room and laid him down for 15 minutes to monitor vitals. Patient got clammy, pale after the vaccine was given, so we treated him with ice to his head and kept him laying down. Dr. monitored his vitals and when his color returned and he could tell us where he was , what his name was and who we were. Dr. stated it would be fine for him to leave with his mother who was driving. Instructed him to go home and take Tylenol and rest.
Age: 17.0
Sex: M
Vaccine: HPV9
Symptoms: Syncope
Clinical narrative: Patient experienced pain in the arm where the shot was given, dizziness, headache and fainting 2 minutes after injection. Patient stated he felt fine right after the vaccine and sat on the table for a minute. But once he got to the front desk he felt faint and sat on the ground. The medical staff took the patient to a open room and laid him down for 15 minutes to monitor vitals. Patient got clammy, pale after the vaccine was given, so we treated him with ice to his head and kept him laying down. Dr. monitored his vitals and when his color returned and he could tell us where he was , what his name was and who we were. Dr. stated it would be fine for him to leave with his mother who was driving. Instructed him to go home and take Tylenol and rest.
Age: 2.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse reaction. Wrong vaccine was given by accident.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Pain, Pyrexia, Swelling, Ultrasound scan normal
Clinical narrative: First 3 days there was swelling, pain and fever followed by weakness in the left arm, intense pain at night, intense pain upon putting on clothes, pain during daily living activities. I'm currently starting physical therapy. I had an arm xray and an ultrasound. Neither showed anything negative, as communicated to me by the Dr.'s nurse.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: X-ray limb normal
Clinical narrative: First 3 days there was swelling, pain and fever followed by weakness in the left arm, intense pain at night, intense pain upon putting on clothes, pain during daily living activities. I'm currently starting physical therapy. I had an arm xray and an ultrasound. Neither showed anything negative, as communicated to me by the Dr.'s nurse.
Age: 6.0
Sex: M
Vaccine: HEPA
Symptoms: Loss of personal independence in daily activities, Malaise, Pyrexia, Vaccination complication, Vomiting
Clinical narrative: Pt's mother called clinic  on 05/15/19, stating that her child had an reaction to the Hep A vaccine that was administered on 05/07/19.  That the child had been having a fever of 102 and vomiting since Monday, 05/13, and not able to attend school.  She had received a call from the school on Monday that the child was sick.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injected limb mobility decreased, Insomnia, Oropharyngeal pain, Pain
Clinical narrative: Later same day, couldn't move left arm well and bad headache.  Couldn't sleep that night.  This morning, 5/17 had fever of 100 and relentless headache, body aches and as of 5pm, fever now just under 101 with added sore throat.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Later same day, couldn't move left arm well and bad headache.  Couldn't sleep that night.  This morning, 5/17 had fever of 100 and relentless headache, body aches and as of 5pm, fever now just under 101 with added sore throat.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: body aches, shivering, slight fever, tiredness
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Rash
Clinical narrative: Patient said she had  redness/rash on upper chest-she couldn't remember exactly what day it started--she thought within 6 days of vaccination
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain, Pain
Clinical narrative: Patient came in to the pharmacy  to pick up her prescription  and told me that she had been experiencing shoulder pain especially when she lifted her arm at an angle.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Skin warm, Swelling
Clinical narrative: red rash, mild swelling and warm to the touch.  patient used cold compress, antihistamine, and tylenol.  reaction appears to be subsiding.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Injection site pain
Clinical narrative: child reports pain at injection site for multiple days after injection in left arm; the pain persists without movement or touching site; mother phones public health office today 5/17/19 to report this adverse event; at this time she reports child states that her arm still hurts but usually only when touching injection site now, and not without movement; no redness (other than scab from injection) or swelling per mothers phone call report
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Lethargy, Pyrexia
Clinical narrative: High fever, swelling, red, hot at shot area.  Lethargic . Vomiting.
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, VARCEL
Symptoms: Vomiting
Clinical narrative: High fever, swelling, red, hot at shot area.  Lethargic . Vomiting.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Back pain, Fatigue, Injection site pain, Malaise
Clinical narrative: Injection side is extremely painful, all over back pain, fatigue, general malaise
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: Patient stated red swollen area around injection site. Also, experienced "flu like" symptoms.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Headache, Malaise, Myalgia, Pain in extremity
Clinical narrative: On the morning after Vaccine patient woke with severe Headache, muscle aches and general feeling of malaise. Arm became red with itching and soreness. Redness traveled down into bicep area. Patient took diphenhydramine and ibuprofen to alleviate the symptoms. Symptoms have improved over the week and arm is just a little red and itchy at this point. Doctor is aware of reaction.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: On the morning after Vaccine patient woke with severe Headache, muscle aches and general feeling of malaise. Arm became red with itching and soreness. Redness traveled down into bicep area. Patient took diphenhydramine and ibuprofen to alleviate the symptoms. Symptoms have improved over the week and arm is just a little red and itchy at this point. Doctor is aware of reaction.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Limb mass, Lip swelling, Pruritus, Rash
Clinical narrative: Patient is experiencing a rash on her midriff, a swollen bottom lip which is impeding speaking, eating, and drinking, and round red welts/lumps on arm and knee that are itchy.  I referred her to visit a hospital emergency room.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Patient is experiencing a rash on her midriff, a swollen bottom lip which is impeding speaking, eating, and drinking, and round red welts/lumps on arm and knee that are itchy.  I referred her to visit a hospital emergency room.
Age: 55.0
Sex: F
Vaccine: TDAP
Symptoms: Malaise, Pyrexia
Clinical narrative: fever of 101 the night of the vaccine and did not feel well
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient states she experienced pain at the injection site the night after she had the dose. She experienced nausea, fever,chills, headache redness and swelling (raised bump) at inejction site the second day after getting the vaccine. Per patient, the swelling and redness is still present at the injection site and the surrounding area of skin as of today (3rd day afte vaccine) but the other symptoms are no longer present
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pyrexia
Clinical narrative: Patient states she experienced pain at the injection site the night after she had the dose. She experienced nausea, fever,chills, headache redness and swelling (raised bump) at inejction site the second day after getting the vaccine. Per patient, the swelling and redness is still present at the injection site and the surrounding area of skin as of today (3rd day afte vaccine) but the other symptoms are no longer present
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Swelling and pain in arm extending distal to elbow, started within 12 hours of injection
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint range of motion decreased, Pain, Swelling
Clinical narrative: Patient complains of pain, swelling and limited range of motion over a month after injection.  Patient has not sought any medical treatment for complaints.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: The day following her 2nd shingles vaccination, patient reported experiencing a slight fever as well as redness/tenderness (about the size of a baseball) located BELOW the injection site. Patient (a retired nurse) insisted on applying pressure to the injection site by pressing on the cotton ball and rubbing it in circles because she felt this would better distribute it into her muscle following the vaccination. She did not treat the symptoms with a pain reliever or ice.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: This was my second shot in the series of two.  Adverse symptoms were :  Sore arm, body aches, nausea, dry heaves, diarrhea, bad headache.  Feeling better now and assume I will continue to do so.  Sick for about 18 hours.  Had only a sore arm after the first injection on February 7 from same Pharmacy.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Retching
Clinical narrative: This was my second shot in the series of two.  Adverse symptoms were :  Sore arm, body aches, nausea, dry heaves, diarrhea, bad headache.  Feeling better now and assume I will continue to do so.  Sick for about 18 hours.  Had only a sore arm after the first injection on February 7 from same Pharmacy.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Loss of consciousness, Pain
Clinical narrative: PATIENT REPORTED FEELING ACHY BODY, DIZZINESS, AND PASSED OUT. THIS ALL OCCURED THE FOLLOWING MORNING AFTER ADMINISTRATION. PATIENT PASSED OUT WHILE MOWING THE GRASS.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous
Clinical narrative: Pt came in on 5/15/19 reporting a red, sore, painful rash that he didn't get with the first dose of the series. Upon follow up with patient on 5/16/19, pt said that the injection site has improved over 24 hours. Pt also noted that he had received the first dose exactly 60 days before his 2nd dose.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Rash erythematous
Clinical narrative: Red and swollen at injection site, appearance of red rash that grew larger and larger around entire upper arm where injection was given.  Very painful.  All symptoms Last for about a week.
Age: 45.0
Sex: F
Vaccine: HEPAB, TDAP
Symptoms: Facial paralysis, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: Pt first had Bell's palsy symptoms approximately 2 weeks after receiving the vaccines. The then progressed to tingliness in tongue, numbness and tingling in mouth, arms, and legs. Was admitted to hospital for 6 days and placed on IV antivirals. Pt released and home. Still has some symptoms in areas listed.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Back pain, Herpes zoster, Rash vesicular
Clinical narrative: I developed shingles (zoster reactivation) in the lumbar region on the left side. The presentation was back pain which preceded the rash by about 3-5 days. The zoster was radicular, in approximately the high lumbar root area, only on the left. The rash did not come fully around to the abdomen. The back pain was severe for about 1 week but not completely incapacitating.  The rash that eventually developed was classic and vesicular. I went my primary care physician just so that the diagnosis could be verified and the physician agreed that this was zoster. I am a neurologist by background and currently work in R&D at a pharmaceutical company. the time course between the vaccine administration (Jan 26 2019) and the onset of the zoster (around Mar 3 2019) was about 5-6 weeks. The zoster pain and rash resolved on its own; I did not take antiviral therapy.
Age: 61.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Red and painful at injection site.  Redness spread around entire bicep.  Pain more significant and prolonged than an average flu shot.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Headache, body aches, low fever, intense shivering  for 12-24 hours; headache continued with mild body aches for two additional days
Age: 26.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test, Colitis microscopic, Colonoscopy, Diarrhoea, Nausea
Clinical narrative: Diarrhea, nausea, vomiting- new dx microscopic colitis from flu shot
Age: 26.0
Sex: F
Vaccine: FLU4
Symptoms: Nuclear magnetic resonance imaging, Stool analysis, Vomiting
Clinical narrative: Diarrhea, nausea, vomiting- new dx microscopic colitis from flu shot
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Malaise, Myalgia, Nausea
Clinical narrative: Chills, shivering, bad muscle aches, nausea, malaise, low energy, still ongoing for two days.
Age: 44.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Erythema, Pruritus
Clinical narrative: 5/17/19 - experienced itching behind right knee in the morning, noticed redness behind right knee in the afternoon. affected area: 6" along leg x 4"across.  Patient applied clobetasol around 1p, redness and itching began to go down.  Patient will visit PCP next monday regarding this reaction.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site pain, Lethargy, Malaise
Clinical narrative: Symptoms included, nausea, headache, lethargy, soreness at sight that radiated somewhat up and down arm, shivering - (fever-like) and general malaise.